Search research articles
Contact Us
Filters
Showing results (211-220 of 223) with videos related to
Page
of 23
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
February 19, 1999
Bolus versus 5-day continuous infusion of cisplatin with mitomycin and vindesine in the treatment of advanced non-small cell lung cancer (NSCLC): a phase III prospective randomised trial of the Italian Oncology Group for Clinical Research (GOIRC)
C Boni, L Savoldi, G Bisagni, et al.
BMC Cancer
|
September 28, 2011
Aurora kinases are expressed in medullary thyroid carcinoma (MTC) and their inhibition suppresses in vitro growth and tumorigenicity of the MTC derived cell line TT
Enke Baldini, Yannick Arlot-Bonnemains, Salvatore Sorrenti, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 24, 2016
Hemophilia and nonprogressing human immunodeficiency virus type 1 infection
E Vicenzi, P Bagnarelli, E Santagostino, et al.
Blood
|
January 1, 1997
Hemophilia and nonprogressing human immunodeficiency virus type 1 infection
E Vicenzi, P Bagnarelli, E Santagostino, et al.
World Neurosurgery
|
October 10, 2025
Perioperative Predictors of Recurrency in Chronic Subdural Hematoma: A Retrospective Analysis of 150 Consecutive Cases
A Fratini, C Noya, S Santi, et al.
Brain Injury
|
November 16, 2020
Psychological status and role of caregivers in the neuro-rehabilitation of patients with severe Acquired Brain Injury (ABI)
U Bivona, D Villalobos, M De Luca, et al.
International Journal of Oncology
|
May 3, 2011
A multicentre, double-blind, randomised trial comparing ondansetron versus ondansetron plus dexamethasone in the prophylaxis of cisplatin-induced delayed emesis
C Gridelli, G Ianniello, G Ambrosini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2017
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
P Bossi, R Miceli, L D Locati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 20, 2019
De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study
V Guarneri, M V Dieci, G Bisagni, et al.
ESMO Real World Data and Digital Oncology
|
April 3, 2026
Second-line therapies after CDK4/6 inhibitor failure in HR-positive/HER2-negative metastatic breast cancer patients: real-world data from the HERMIONE-13 study
M E Cazzaniga, V Cogliati, E Rossi, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 223) with videos related to
Sort By:
Page
of 23
European Journal of Cancer (Oxford, England : 1990)
|
February 19, 1999
Bolus versus 5-day continuous infusion of cisplatin with mitomycin and vindesine in the treatment of advanced non-small cell lung cancer (NSCLC): a phase III prospective randomised trial of the Italian Oncology Group for Clinical Research (GOIRC)
C Boni, L Savoldi, G Bisagni, et al.
BMC Cancer
|
September 28, 2011
Aurora kinases are expressed in medullary thyroid carcinoma (MTC) and their inhibition suppresses in vitro growth and tumorigenicity of the MTC derived cell line TT
Enke Baldini, Yannick Arlot-Bonnemains, Salvatore Sorrenti, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 24, 2016
Hemophilia and nonprogressing human immunodeficiency virus type 1 infection
E Vicenzi, P Bagnarelli, E Santagostino, et al.
Blood
|
January 1, 1997
Hemophilia and nonprogressing human immunodeficiency virus type 1 infection
E Vicenzi, P Bagnarelli, E Santagostino, et al.
World Neurosurgery
|
October 10, 2025
Perioperative Predictors of Recurrency in Chronic Subdural Hematoma: A Retrospective Analysis of 150 Consecutive Cases
A Fratini, C Noya, S Santi, et al.
Brain Injury
|
November 16, 2020
Psychological status and role of caregivers in the neuro-rehabilitation of patients with severe Acquired Brain Injury (ABI)
U Bivona, D Villalobos, M De Luca, et al.
International Journal of Oncology
|
May 3, 2011
A multicentre, double-blind, randomised trial comparing ondansetron versus ondansetron plus dexamethasone in the prophylaxis of cisplatin-induced delayed emesis
C Gridelli, G Ianniello, G Ambrosini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2017
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
P Bossi, R Miceli, L D Locati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 20, 2019
De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study
V Guarneri, M V Dieci, G Bisagni, et al.
ESMO Real World Data and Digital Oncology
|
April 3, 2026
Second-line therapies after CDK4/6 inhibitor failure in HR-positive/HER2-negative metastatic breast cancer patients: real-world data from the HERMIONE-13 study
M E Cazzaniga, V Cogliati, E Rossi, et al.
Page
of 23